Cargando…
Towards Enhanced MRI Performance of Tumor-Specific Dimeric Phenylboronic Contrast Agents
It is known that phenylboronic acid (PBA) can target tumor tissues by binding to sialic acid, a substrate overexpressed by cancer cells. This capability has previously been explored in the design of targeting diagnostic probes such as Gd- and (68)Ga-DOTA-EN-PBA, two contrast agents for magnetic reso...
Autores principales: | Martinelli, Jonathan, Tei, Lorenzo, Geninatti Crich, Simonetta, Alberti, Diego, Djanashvili, Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003780/ https://www.ncbi.nlm.nih.gov/pubmed/33808910 http://dx.doi.org/10.3390/molecules26061730 |
Ejemplares similares
-
Efficient Route to Label Mesenchymal Stromal Cell-Derived
Extracellular Vesicles
por: Alberti, Diego, et al.
Publicado: (2018) -
LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications
por: Rakhshan, Sahar, et al.
Publicado: (2021) -
Highly Sensitive “Off/On” EPR Probes to Monitor Enzymatic Activity
por: Elkhanoufi, Sabrina, et al.
Publicado: (2022) -
Polymerizable Gd(iii) building blocks for the synthesis of high relaxivity macromolecular MRI contrast agents
por: Berki, Thomas R., et al.
Publicado: (2021) -
In vitro and in vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells
por: Alberti, Diego, et al.
Publicado: (2020)